From: SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma
Variables | SLC39A6 expression in Han ethnic | SLC39A6 expression in Kazakh ethnic | ||||||
---|---|---|---|---|---|---|---|---|
Total cases | Low n (%) | High n (%) | P value | Total cases | Low n (%) | High n (%) | P value | |
Gender | Â | Â | Â | 0.863 | Â | Â | Â | 0.621 |
 Male | 107 | 35 (32.71) | 72 (67.29) |  | 53 | 12 (22.64) | 41 (77.36) |  |
 Female | 35 | 12 (34.29) | 23 (65.71) |  | 33 | 6 (18.18) | 27 (81.82) |  |
Age (years) | Â | Â | Â | 0.254 | Â | Â | Â | 0.113 |
 ≤60 | 57 | 22 (38.60) | 35 (61.40) |  | 53 | 14 (26.42) | 39 (73.58) |  |
 >60 | 85 | 25 (29.41) | 60 (70.59) |  | 33 | 4 (12.12) | 29 (87.88) |  |
Differentiationa | Â | Â | Â | 0.018 | Â | Â | Â | 0.003 |
 Well | 39 | 20 (51.28) | 19 (48.72) |  | 21 | 10 (47.62) | 11 (52.38) |  |
 Moderate | 74 | 19 (25.68) | 55 (74.32) |  | 53 | 6 (11.32) | 47 (88.68) |  |
 Poor | 29 | 8 (27.59) | 21 (72.41) |  | 12 | 2 (16.67) | 10 (83.33) |  |
Lymph node metastasis | Â | Â | Â | 0.050 | Â | Â | Â | 0.690 |
 No | 93 | 36 (38.71) | 57 (61.29) |  | 37 | 7 (18.92) | 30 (81.08) |  |
 Yes | 49 | 11 (22.45) | 38 (77.55) |  | 49 | 11 (22.45) | 38 (77.55) |  |
TNM stage | Â | Â | Â | 0.276 | Â | Â | Â | 0.026 |
 I + II | 94 | 34 (36.17) | 60 (63.83) |  | 53 | 7 (13.21) | 46 (86.79) |  |
 III + IV | 48 | 13 (27.01) | 35 (72.99) |  | 33 | 11 (33.33) | 22 (66.67) |  |